FLT-3 inhibitor
FLT-3 inhibitor: A gene-targeted therapy for a common subtype of acute myeloid leukemia (AML) known as FLT-positive AML in which there is a FLT3 receptor mutation. The FLT-3 inhibitor is a tyrosine kinase inhibitor that interferes with abnormal FLT3 function by preventing essential proteins from binding to the DNA. The FLT-3 inhibitor blocks the action of the altered FLT-3 gene, rendering it powerless. Sorafenib and others are in clinical trials as FLT-3 inhibitors for AML.
Read Also:
- Flu
Flu: Flu is a colloquialism for influenza. The flu is an acute respiratory illness caused by influenza viruses A or B . Most people who get the flu recover completely in 1 to 2 weeks, but some people develop serious and potentially life-threatening medical complications, such as pneumonia. Much of the illness and death caused […]
- Flu shot
The flu (influenza) vaccine is recommended annually (each year) for persons at high risk for serious complications from influenza virus infection. This includes: Everyone age 65 or more; People with chronic diseases of the heart; People with chronic diseases of the lung; People with chronic diseases of the kidneys; People with diabetes; People with immunosuppression; […]
- Flu vaccine
In 2010, the United States Advisory Committee on Immunization Practices (ACIP) expanded the recommendation for influenza vaccination to include all individuals six months of age and older. Vaccines are available for people with an allergy to eggs.
- Flu, stomach
Flu, stomach: A gastrointestinal illness caused by a microorganism. Stomach flu is not related to the influenza (flu) virus.
- Fluctuating rib
Fluctuating rib: One of the last two ribs. A rib is said to be “fluctuating” if it does not attach to the sternum (the breast bone) or to another rib. There are usually 12 pairs of ribs in all. Each pair of ribs is attached to the building blocks of the spine (the vertebrae) in […]